Revelation Biosciences (REVB)
(Delayed Data from NSDQ)
$1.81 USD
+0.01 (0.56%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $1.81 0.00 (0.00%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/9/24 |
---|---|
Current Quarter | -1.81 |
EPS Last Quarter | -2.46 |
Last EPS Surprise | 54.36% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -7.54 |
Next Year | -5.24 |
EPS (TTM) | -30.61 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.81 | -2.09 | -7.54 | -5.24 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -1.81 | -2.09 | -7.54 | -5.24 |
High Estimate | -1.34 | -1.44 | -5.44 | -3.47 |
Low Estimate | -2.27 | -2.73 | -9.63 | -7.00 |
Year ago EPS | -7.51 | -12.31 | -36.96 | -7.54 |
Year over Year Growth Est. | 75.90% | 83.02% | 79.60% | 30.50% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.81 | -2.09 | -7.54 | -5.24 |
7 Days Ago | -1.81 | -2.09 | -7.54 | -5.24 |
30 Days Ago | -1.81 | -2.09 | -7.54 | -5.24 |
60 Days Ago | -1.81 | -2.09 | -7.54 | -5.24 |
90 Days Ago | -5.18 | -5.21 | -20.32 | -18.88 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.81 | -2.09 | -7.54 | -5.24 |
Zacks Consensus Estimate | -1.81 | -2.09 | -7.54 | -5.24 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.46 | -8.33 | -12.31 | -7.51 | NA |
Estimate | -5.39 | -10.94 | -9.01 | -9.91 | NA |
Difference | 2.93 | 2.61 | -3.30 | 2.40 | 1.16 |
Surprise | 54.36% | 23.86% | -36.67% | 24.24% | 16.45% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more